Literature DB >> 23370773

Fuhrman grade [corrected] has no added value in prediction of mortality after partial or [corrected] radical nephrectomy for chromophobe renal cell carcinoma patients.

Malek Meskawi1, Maxine Sun, Salima Ismail, Marco Bianchi, Jens Hansen, Zhe Tian, Nawar Hanna, Quoc-Dien Trinh, Markus Graefen, Francesco Montorsi, Paul Perrotte, Pierre I Karakiewicz.   

Abstract

Our objective was to test whether Fuhrman grade [corrected] (FG) is applicable in the context of chromophobe renal cell carcinoma patients treated with partial and radical nephrectomy. Patients (n=1862) with chromophobe renal cell carcinoma treated with partial and radical nephrectomy were identified within the Surveillance, Epidemiology, and End Results (1988-2008). Univariable and multivariable Cox regression analyses were fitted to predict cancer-specific mortality. Discriminant properties were assessed for the conventional four-tiered FG scheme. Additionally, discrimination of the three-tiered FG scheme (1-2 vs 3 vs 4) and the two-tiered FG scheme (1-2 vs 3-4) was also assessed. The statistical significance of the differences in accuracy estimates was compared using the Mantel-Haenszel test. A total of 65 of the 1862 died of the disease. The overall 5-year cancer-specific mortality-free survival rate was 94.8% (95% confidence interval: 93.5-96.2). In univariable analyses, none of the FG strata were significantly associated with cancer-specific mortality. Furthermore, FG was less informative (63%) than tumor size (72%) and tumor stage (69%), using measures of discrimination in univariable analyses. After accounting for all covariates, prediction of 5-year cancer-specific mortality was 79.0% vs 80.3% accurate, respectively, with vs without the consideration of FG (P=0.01). Similar discrimination estimates were obtained for the modified three-tiered FG scheme (78.5%; P=0.009) and the modified two-tiered FG scheme (79.5%; P=0.02). In conclusion, FG is not an informative predictor of prognosis, defined as cancer-specific mortality, after partial and radical nephrectomy for chromophobe renal cell carcinoma patients.

Entities:  

Mesh:

Year:  2013        PMID: 23370773     DOI: 10.1038/modpathol.2012.230

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  4 in total

1.  Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma.

Authors:  F Cornelis; E Tricaud; A S Lasserre; F Petitpierre; J C Bernhard; Y Le Bras; M Yacoub; M Bouzgarrou; A Ravaud; N Grenier
Journal:  Eur Radiol       Date:  2014-08-13       Impact factor: 5.315

2.  Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma.

Authors:  Joana B Neves; Leyre Vanaclocha Saiz; Saeed Dabestani; Maxine G B Tran; Axel Bex; Yasmin Abu-Ghanem; Marta Marchetti; My-Anh Tran-Dang; Soha El-Sheikh; Ravi Barod; Christian Beisland; Umberto Capitanio; David Cullen; Tobias Klatte; Börje Ljungberg; Faiz Mumtaz; Prasad Patki; Grant D Stewart
Journal:  World J Urol       Date:  2021-04-13       Impact factor: 4.226

3.  BSND and ATP6V1G3: Novel Immunohistochemical Markers for Chromophobe Renal Cell Carcinoma.

Authors:  Kazuya Shinmura; Hisaki Igarashi; Hisami Kato; Kenji Koda; Hiroshi Ogawa; Seishiro Takahashi; Yoshiro Otsuki; Tatsuaki Yoneda; Yuichi Kawanishi; Kazuhito Funai; Tatsuya Takayama; Seiichiro Ozono; Haruhiko Sugimura
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

4.  Predictive models composed by radiomic features extracted from multi-detector computed tomography images for predicting low- and high- grade clear cell renal cell carcinoma: A STARD-compliant article.

Authors:  Xiaopeng He; Hanmei Zhang; Tong Zhang; Fugang Han; Bin Song
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.